Fukuoka, Japan

Naotaka Hamasaki

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 1988-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Naotaka Hamasaki: Innovator in Cancer Detection and Biochemical Processes

Introduction

Naotaka Hamasaki is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the fields of cancer detection and biochemical processes. With a total of 3 patents to his name, Hamasaki's work has the potential to impact medical diagnostics and treatment.

Latest Patents

Hamasaki's latest patents include a method for detecting colorectal cancer in its early stages. This innovative approach utilizes a tumor marker comprising diacetylspermine. The method involves reacting an antibody to diacetylspermine with a biological sample to detect the presence of this marker. The results obtained from this detection serve as an indicator for evaluating the state of the tumor. Additionally, he has developed a process for preparing monosodium phosphoenolpyruvate, which involves subjecting monosodium monosubstituted phosphoenolpyruvate to specific chemical processes.

Career Highlights

Throughout his career, Naotaka Hamasaki has worked with notable organizations, including Ube Industries, Inc. and the Japanese Red Cross Society. His experience in these companies has allowed him to apply his innovative ideas in practical settings, contributing to advancements in technology and healthcare.

Collaborations

Hamasaki has collaborated with esteemed colleagues such as Shigeru Sasakawa and Masayuki Shiba. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Naotaka Hamasaki's contributions to cancer detection and biochemical processes highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to advancing medical science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…